Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of North Central India

被引:14
|
作者
Prakash, Ravi [1 ,2 ,3 ]
Kumar, Dilip [3 ]
Gupta, Vinod K. [4 ]
Jain, Sanjay [5 ]
Chauhan, Devendra S. [3 ]
Tiwari, Pramod K. [1 ,2 ]
Katoch, Vishwa M. [6 ,7 ]
机构
[1] Jiwaji Univ, Ctr Genom, Gwalior 474011, India
[2] Jiwaji Univ, Sch Studies Zool, Gwalior 474011, India
[3] Natl JALMA Inst Leprosy & Other Mycobacerial Dis, Dept Mol Biol & Microbiol, Agra 282004, Uttar Pradesh, India
[4] Dist TB Hlth Soc, Gwalior, India
[5] Dist Hosp, Revised Natl TB Control Programe, Sheopur, India
[6] Govt India, Minist Hlth & Family Welf, Dept Hlth Res, New Delhi, India
[7] Indian Council Med Res, New Delhi 110029, India
关键词
Sahariya tribe; Mycobacterium tuberculosis; MDR-TB; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RISK-FACTORS; DRUG-RESISTANCE; HIGH PREVALENCE; MADHYA-PRADESH; PREDOMINANCE; SENSITIVITY; POPULATION; STRAINS;
D O I
10.1016/j.jiph.2015.10.008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The incidence/prevalence of tuberculosis (TB) is reported to be high in the Sahariya tribe of North Central India. The outbreaks of different drug-resistant isolates of Mycobacterium tuberculosis emphasized the need for continuous monitoring of resistance to anti-tuberculosis drugs. This study aimed to assess the profile of multidrug resistant TB among the Sahariya tribe and their non-tribal neighbors for first line drugs through field-based investigations. Methodology: A total of 274 sputum positive pulmonary TB individuals were enrolled and studied for their drug susceptibility profile by the proportion method. Results: A total of 21 cases from Sahariya and 6 from non-tribes were identified with MDR-TB. Thus Sahariya tribe showed a 1.95-fold increased risk of developing drug resistance than non-tribes. Significant differences were observed for developing drug sensitivity between Sahariya males and females when analyzed for resistance developed to any drug and overall drug resistance vs. sensitive isolates, respectively. A 4.46-fold risk was found for MDR-TB among the smokers of Sahariya tribe, whereas, the non-tribes did not show any significant association. Conclusion: The drug susceptibility profile developed in the present study indicates that drug-resistant tuberculosis is emerging as a serious public health concern in Sahariya tribe. Urgent and effective control measures and better management policies are needed for the prevention of MDR-TB in the tribe. (C) 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
引用
收藏
页码:289 / 297
页数:9
相关论文
共 50 条
  • [21] Management of multidrug resistant tuberculosis (MDR-TB) - Monitoring is the key to successful outcome
    Akshata, J. S.
    Chakrabarthy, Anushree
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2016, 65 (02): : 447 - 450
  • [22] Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region
    Karaman, Onur
    Varol, Yelda
    Bicmen, Can
    Akarca, Tulay
    Dereli, Sevket
    Ozbakir, Didem
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [23] Multidrug resistant tuberculosis (MDR-TB) incidence in close contacts of pulmonary MDR-TB index cases in East London - a retrospective study
    Tuma, Ricardo de Luca e
    Jama, Amina
    Dart, Susan
    White, Veronica
    Chen, Christabelle
    Kunst, Heinke
    Smallcombe, Nicola
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [24] GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB)
    Mokaddas, E. M.
    Ahmad, S.
    Eldeen, H. S.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (06)
  • [25] Knowledge, Attitudes And Practices About Multidrug-Resistant Tuberculosis (mdr-Tb) And Preventive Therapy Among Adult And Adolescent Household Contacts Of Mdr-Tb Index Cases
    Suryavanshi, N.
    Murrill, M.
    Gupta, A.
    Hesseling, A.
    Naini, L.
    Jones, L.
    Hughes, M.
    Kim, S.
    Smith, B.
    Gupte, N.
    Dawson, R.
    Mave, V.
    Mendoza, A.
    Gonzales, P.
    Kumarasamy, N.
    Comins, K.
    Conradie, F.
    Shenje, J.
    Fontain, S. Nerette
    Garcia-Prats, A.
    Asemelash, A.
    Nedsuwan, S.
    Peters, D.
    Lalloo, U.
    Garcia Ferreira, A.
    Okeyo, E.
    Swindells, S.
    Churchyard, G.
    Shah, N. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [26] Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB) - a report of ten cases
    von der Lippe, B
    Sandven, P
    Brubakk, O
    JOURNAL OF INFECTION, 2006, 52 (02) : 92 - 96
  • [27] Progress in the roll-out of multidrug-resistant tuberculosis (MDR-TB) treatments
    Heng, M.
    Allmendinger, S.
    Chiang, C-Y.
    Trebucq, A.
    Horsburgh, C. R., Jr.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (05) : 535 - 536
  • [28] A comparative clinical trial of ofloxacin in the treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
    Hussein, AAA
    Al-Akshar, HM
    Ads, AR
    El-Taieb, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A554 - A554
  • [29] Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Sabur, Natasha F.
    Brar, Mantaj S.
    Wu, Lisa
    Brode, Sarah K.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [30] Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives
    Rendon, Adrian
    Tiberi, Simon
    Scardigli, Anna
    D'Ambrosio, Lia
    Centis, Rosella
    Caminero, Jose A.
    Migliori, Giovanni Battista
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : 2666 - 2671